Promise - Fall 2011
Research discoveries made at MD Anderson are leading to improved therapies for cancer patients. Here are some recent advances. Select any headline to read more about that topic.
The National Lung Screening Trial is the driving force behind MD Anderson's new program enabling current and former heavy smokers to receive more effective lung cancer screening.
The first comprehensive studies of genetic variation in head and neck squamous cell cancers have uncovered mutations that may help refine treatment, say MD Anderson researchers.
A team led by MD Anderson reports in the journal Nature Medicine that a regulatory T cell expressing three specific genes shuts down the mass production of antibodies launched by the immune system to attack invaders.
Visit the MD Anderson Newsroom for more on these and other topics.